Tulyp Medical emerges from Sofinnova’s medtech accelerator and announces FDA submission following initial first-in-human use
- Company unveils patented technology designed to help maintain healthy blood flow during vascular procedures
- Backed by Sofinnova MD Start and led by experienced medtech entrepreneurs and cardiologists
PARIS, France – November 4, 2025 – Tulyp Medical, a Paris-based startup developing a medical device for intelligent pressure-driven perfusion, emerged from stealth and announced it has submitted its 510(k) application to the U.S. Food and Drug Administration (FDA). The company’s debut follows positive results from its initial first-in-human study.
